Suvoda provides a SaaS solution for pharmaceutical and biotechnology companies to manage complex trial designs and optimize the supply chain across the clinical trial continuum. Its Interactive Response Technology (IRT) system includes configurable and customizable features, reporting, and advanced functionality built to support complex and innovative study designs. The company serves customers and end-users in 62 countries and operates four offices in the U.S. and Europe. In six years Suvoda has grown organically from a six-person startup to a staff of 386. Led by President & CEO Jagath Wanninayake, the company targets studies ranging from small investigator-sponsored trials to large global Phase III studies. Suvoda intends to use recent funding to continue growth and expand its product offerings.

Total raised

$40M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2019